Cargando…

Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease (CLD). NAFLD is also related to obesity and metabolic syndromes, which are common in Saudi Arabia. However, it is yet unclear what proportion of CLD cases is because of NAFLD in Saudi Arabia. OBJECTIVE: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallatah, Hind Ibrahim, Al-Dabbagh, Ammar, Hiejazi, Mohammead T., Hanbazazah, Sulaiman A. A., Hussein, Ali O., Al-Sahafi, Majed A., Akbar, Hisham O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305671/
https://www.ncbi.nlm.nih.gov/pubmed/32587493
http://dx.doi.org/10.4103/sjmms.sjmms_272_19
_version_ 1783548512529547264
author Fallatah, Hind Ibrahim
Al-Dabbagh, Ammar
Hiejazi, Mohammead T.
Hanbazazah, Sulaiman A. A.
Hussein, Ali O.
Al-Sahafi, Majed A.
Akbar, Hisham O.
author_facet Fallatah, Hind Ibrahim
Al-Dabbagh, Ammar
Hiejazi, Mohammead T.
Hanbazazah, Sulaiman A. A.
Hussein, Ali O.
Al-Sahafi, Majed A.
Akbar, Hisham O.
author_sort Fallatah, Hind Ibrahim
collection PubMed
description BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease (CLD). NAFLD is also related to obesity and metabolic syndromes, which are common in Saudi Arabia. However, it is yet unclear what proportion of CLD cases is because of NAFLD in Saudi Arabia. OBJECTIVE: To investigate the prevalence and clinical characteristics of NAFLD among patients with CLD in Saudi Arabia. MATERIALS AND METHODS: This retrospective study included all patients with any CLD who had successfully undergone transient elastography (FibroScan) examination at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between April 2015 and April 2018. These CLD patients were then grouped as NAFLD and non-NAFLD patients. Serum hemoglobin, alanine aminotransferase, gamma-glutamyl transferase, albumin and bilirubin levels; platelet count and international normalized ratio within 1 month after the FibroScan examination were assessed. For NAFLD patients, glycated hemoglobin levels and abdominal ultrasound examination results were also assessed. Statistical analysis was carried out using Student’s t-test and linear regression. RESULTS: The prevalence of NAFLD among CLD patients was 22.5% (111 of 494 CLD patients), and it was the third most common CLD after chronic hepatitis B and C. Compared with non-NAFLD patients, NAFLD patients had significantly higher mean age (53.65 ± 12.7 vs. 48.07 ± 14.6 years; P < 0.001), mean serum alanine aminotransferase level (61.84 vs. 50.23 IU/L; P < 0.001) and mean controlled attenuation parameter (297.83 vs. 238.41; P < 0.001). NAFLD patients also had a higher rate of ultrasound-detected features of cirrhosis (16.2% vs. 3.7%, P < 0.001), but there was no significant difference in fibrosis severity. In addition, their mean glycated hemoglobin level (6.85) was elevated (range: 5–13). Age and platelet count were significantly correlated with presence of cirrhosis. CONCLUSION: NAFLD is the third most common CLD in Western Saudi Arabia, and it is associated with older age and metabolic syndromes, with one-third of the patients having advanced fibrosis or cirrhosis.
format Online
Article
Text
id pubmed-7305671
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-73056712020-06-24 Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah Fallatah, Hind Ibrahim Al-Dabbagh, Ammar Hiejazi, Mohammead T. Hanbazazah, Sulaiman A. A. Hussein, Ali O. Al-Sahafi, Majed A. Akbar, Hisham O. Saudi J Med Med Sci Original Article BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease (CLD). NAFLD is also related to obesity and metabolic syndromes, which are common in Saudi Arabia. However, it is yet unclear what proportion of CLD cases is because of NAFLD in Saudi Arabia. OBJECTIVE: To investigate the prevalence and clinical characteristics of NAFLD among patients with CLD in Saudi Arabia. MATERIALS AND METHODS: This retrospective study included all patients with any CLD who had successfully undergone transient elastography (FibroScan) examination at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between April 2015 and April 2018. These CLD patients were then grouped as NAFLD and non-NAFLD patients. Serum hemoglobin, alanine aminotransferase, gamma-glutamyl transferase, albumin and bilirubin levels; platelet count and international normalized ratio within 1 month after the FibroScan examination were assessed. For NAFLD patients, glycated hemoglobin levels and abdominal ultrasound examination results were also assessed. Statistical analysis was carried out using Student’s t-test and linear regression. RESULTS: The prevalence of NAFLD among CLD patients was 22.5% (111 of 494 CLD patients), and it was the third most common CLD after chronic hepatitis B and C. Compared with non-NAFLD patients, NAFLD patients had significantly higher mean age (53.65 ± 12.7 vs. 48.07 ± 14.6 years; P < 0.001), mean serum alanine aminotransferase level (61.84 vs. 50.23 IU/L; P < 0.001) and mean controlled attenuation parameter (297.83 vs. 238.41; P < 0.001). NAFLD patients also had a higher rate of ultrasound-detected features of cirrhosis (16.2% vs. 3.7%, P < 0.001), but there was no significant difference in fibrosis severity. In addition, their mean glycated hemoglobin level (6.85) was elevated (range: 5–13). Age and platelet count were significantly correlated with presence of cirrhosis. CONCLUSION: NAFLD is the third most common CLD in Western Saudi Arabia, and it is associated with older age and metabolic syndromes, with one-third of the patients having advanced fibrosis or cirrhosis. Wolters Kluwer - Medknow 2020 2020-04-17 /pmc/articles/PMC7305671/ /pubmed/32587493 http://dx.doi.org/10.4103/sjmms.sjmms_272_19 Text en Copyright: © 2020 Saudi Journal of Medicine & Medical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Fallatah, Hind Ibrahim
Al-Dabbagh, Ammar
Hiejazi, Mohammead T.
Hanbazazah, Sulaiman A. A.
Hussein, Ali O.
Al-Sahafi, Majed A.
Akbar, Hisham O.
Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah
title Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah
title_full Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah
title_fullStr Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah
title_full_unstemmed Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah
title_short Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah
title_sort prevalence and clinical characteristics of nafld in chronic liver disease patients from king abdulaziz university hospital, jeddah
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305671/
https://www.ncbi.nlm.nih.gov/pubmed/32587493
http://dx.doi.org/10.4103/sjmms.sjmms_272_19
work_keys_str_mv AT fallatahhindibrahim prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah
AT aldabbaghammar prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah
AT hiejazimohammeadt prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah
AT hanbazazahsulaimanaa prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah
AT husseinalio prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah
AT alsahafimajeda prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah
AT akbarhishamo prevalenceandclinicalcharacteristicsofnafldinchronicliverdiseasepatientsfromkingabdulazizuniversityhospitaljeddah